BCTX

Briacell Therapeutics Corp

NASDAQ: BCTX · HEALTHCARE · BIOTECHNOLOGY

$3.01

-2.59% today

Updated 2026-11-03

Market cap

$26.55M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.92

Dividend yield

—

52W range

$3 – $13

Volume

0.1M

Market cap

$26.55M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.92

Dividend yield

—

52W range

$3 – $13

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →252 stocks currently score above 75

Price targets

Analyst target

$150.00

+4883.39%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-28.78M

Key financials

Revenue Net Income Free Cash Flow

Metric	2023	2024	2025	2026	TTM
Revenue	$0.00	$0.00	—	—	—
Net income	$-27.11M	$-4.79M	$-36.49M	$-34.90M	$-34.90M
EPS	—	—	—	—	$-0.92
Free cash flow	$-31.89M	$-33.59M	$-39.07M	$-28.78M	$-28.78M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BCTX	$26.55M	23	4.3	3.0	5.0	5.0	—	Avoid
LLY	$1.26T	74	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$657.68B	54	4.7	8.5	2.7	5.5	-89.35%	Buy
ABBV	$521.11B	77	6.7	9.0	4.0	5.0	-88.02%	Strong Buy
MRK	$368.89B	44	3.3	6.5	2.0	5.0	-76.61%	Hold
UNH	$365.29B	62	6.7	6.0	4.7	5.5	-24.78%	Buy

Smart narrative

Briacell Therapeutics Corp trades at $3.01. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score.

Frequently asked questions

What is Briacell Therapeutics Corp's stock price?

Briacell Therapeutics Corp (BCTX) trades at $3.01.

Is Briacell Therapeutics Corp overvalued?

Briacell Therapeutics Corp carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Briacell Therapeutics Corp (BCTX)?

The 12-month analyst consensus target is $150.00, about 4883.4% above the current $3.01. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-124.86%

Beta1.51

50D MA$3.77

200D MA$3.81

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BCTX vs LLY →BCTX vs JNJ →BCTX vs ABBV →Stock screener →